Literature DB >> 1567293

Evaluation of serum beta 2-microglobulin in oral cancer.

W Manzar1, M R Raghavan, A R Aroor, K R Keshavamurthy.   

Abstract

Beta 2-microglobulin (beta 2-m) low molecular mass protein was measured in serum of normal subjects and in patients with oral cancer. There was a significant increase in beta 2-m levels in oral cancer patients. The possible role of beta 2-m as a biochemical parameter and its significance in oral cancer is discussed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1567293     DOI： 10.1111/j.1834-7819.1992.tb00832.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN： 0045-0421            Impact factor:   2.291


  3 in total

1.  Estimation of serum β2-microglobulin in potentially malignant disorders and squamous cell carcinoma of the oral cavity: A clinicopathological study.

Authors:  Anand Pratap Singh; Nitin Kumar; Manthena Srinivasa Raju; Narendra Nath Singh; Suma Gundareddy Nagendrareddy
Journal:  Dent Res J (Isfahan)       Date:  2014-01

2.  Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.

Authors:  Wenwen Sun; Lu Gui; Xulei Zuo; Lingyun Zhang; Daibing Zhou; Xiaoling Duan; Weimin Ren; Guoxiong Xu
Journal:  J Transl Med       Date:  2016-03-16       Impact factor: 5.531

3.  Blood biomarkers in adults with lymph node enlargement contribute to diagnostic significance of malignancy.

Authors:  Shanshan Ma; Junbin Guo; Danlei Lu; Lixia Zhu; Meng Zhou; Li Li; Jingjing Zhu; Xiudi Yang; Yanlong Zheng; Xiujin Ye; Wanzhuo Xie
Journal:  Oncotarget       Date:  2017-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.